Although there are limitations to the experimental diabetic mouse model compared to humans (Wu and Huan, 2007; Müller et al., 2012), STZ-induced diabetic ApoE−/− mouse is an interesting model for exploring new therapeutic options for diabetes-associated dyslipidemia and renal injury. Here, APOE is linked to metabolic syndrome.